David D Muth - Net Worth and Insider Trading
David D Muth Net Worth
The estimated net worth of David D Muth is at least $1 Million dollars as of 2024-11-13. David D Muth is the EVP, Chief Commercial Officer of Catalyst Pharmaceuticals Inc and owns about 44,700 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $1 Million. Details can be seen in David D Muth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David D Muth has not made any transactions after 2015-05-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David D Muth
David D Muth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David D Muth owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of David D Muth’s form 4 insider trades.
Insider Ownership Summary of David D Muth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2015-05-01 | Exec. V.P. & Corp. Development |
David D Muth Latest Holdings Summary
David D Muth currently owns a total of 1 stock. David D Muth owns 44,700 shares of Catalyst Pharmaceuticals Inc (CPRX) as of May 1, 2015, with a value of $1 Million.
Latest Holdings of David D Muth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2015-05-01 | 44,700 | 23.04 | 1,029,888 |
Holding Weightings of David D Muth
David D Muth Form 4 Trading Tracker
According to the SEC Form 4 filings, David D Muth has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the acquisition of 1,700 shares on May 1, 2015, which cost David D Muth around $5,440.
Insider Trading History of David D Muth
- 1
David D Muth Trading Performance
GuruFocus tracks the stock performance after each of David D Muth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David D Muth is 47.84%. GuruFocus also compares David D Muth's trading performance to market benchmark return within the same time period. The performance of stocks bought by David D Muth within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David D Muth's insider trading performs compared to the benchmark.
Performance of David D Muth
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.03 | | | | | |
| Relative Return to S&P 500(%) | 16.8 | | | | | |
David D Muth Ownership Network
Ownership Network List of David D Muth
Ownership Network Relation of David D Muth
David D Muth Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
David D Muth is the Exec. V.P. & Corp. Development of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, David D Muth made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .
In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
David D Muth Mailing Address
Above is the net worth, insider trading, and ownership report for David D Muth. You might contact David D Muth via mailing address: Catalyst Pharmaceutical Partners, Inc., 355 Alhambra Circle, Suite 1500, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
